Hysterectomy, oophorectomy, and heart disease risk factors in older women

American Journal of Public Health

Volumn 87, Issue 4, 1997, Pages 676-680

  Kritz Silverstein, Donna ^a   Barrett Connor, Elizabeth ^a   Wingard, Deborah L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ESTROGEN THERAPY; FEMALE; HEART DISEASE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVARIECTOMY; POSTOPERATIVE COMPLICATION; RISK FACTOR;

EID: 0030912757     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.4.676     Document Type: Article

References (32)

1. National Center for Health Statistics. Health United States, 1994. Hyattsville, Md: Public Health Service; 1995.
2. Greenwood S. Hysterectomy and ovarian removal-a major health issue in the pcrimenopausal years. West J Med. 1988; 149:771-772.
3. Pokras R, Hufnagel VG. Hysterectomy in the United States, 1965-84. Am J Public Health. 1988;78:852-853.
4. Sightler SE, Boike GM, Estape RE, Averette HE. Ovarian cancer in women with prior hysterectomy: a 14-year experience at the University of Miami. Obstet Gynecol. 1991:78:681-684.
5. Colditz GA, Willen WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. TV Engl J Med. 1987;316: 1105-1110.
6. Rosenberg L, Hennekens CH, Rosner B, Bellanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 1981:139:47-51.
7. Witteman JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ. 1989;298:642-644.
8. Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol. 1992; 136: 408-416.
9. Luoto R, Kaprio J, Reunanen A, Rutanen E-M. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol. 1995;85:515-522.
10. Gordon T, Kännel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: the Framingham Study. Aim Intern Med. 1978;89:157-161.
11. Ritterband AB, Jaffee IA, Densen PM, Magagna JF, Reed E. Gonadal function and the development of coronary heart disease. Circulation. 1963;27:237-25I.
12. Parish E, Fletcher CD, Hart DM, Smith ML. Effects of bilateral oophorectomy on lipoprotein metabolism. Brj Obstet Gynaecol. 1990;97:78-82.
13. Castelo-Branco C, Casals E, Stenllehy C, Gonzalez-Merlo J, Iglesias X. Effects of oophorectomy and hormone replacement therapy on plasma lipids. Matiiritas. 1993; 17:113-122.
14. Pansini F, Bonaccorso G, Calisesi M, et al. Influence of spontaneous and surgical menopause on atherogenic metabolic risk. Matiiritas. 1993;17:181-190.
15. Punnonen R, Rauramo L. The effect of castration and estrogen therapy on serum high-density lipoprotein cholesterol. Art J Gynaecol Obstet. 1980; 17:434-436.
16. Pansini F, Bergamini C, Bettocchi Jr S, et al. Short-term effect of oophorectomy on lipoprotein metabolism. Gynecol Obstet Invest. 1984;18:134-139.
17. Punnonn R, Rauramo L. Effect of bilateral oophorectomy and peroral estradiol valerate therapy on serum lipids. Int J Gynaecol Obstet. 1976;14:13-16.
18. Lipid Research Clinics Program. Manual of Laboratory Operations. Vol 1. Lipid and Lipoprotein Analysis. 2nd ed. Washington, DC: National Institutes of Health; 1974. DHEW publication NIH 75-628.
19. Friedwald WJ, Levy RI, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:459-502.
20. Desbuquois B, Ausbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab. 1971;334:732-738.
21. Wakatsuki A, Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol. 1995;85: 523-528.
22. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. .MAM. 1995;273:199-208.
23. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. Comparison of oral estrogens and estrogen plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Cynecol 1995;85:529-537.
24. Griffin B, Farrish E, Walsh D, et al. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause. Clin Endocrinol (Oxf). 1993;39:463-468.
25. Sonnendecker EWW, Polakow ES. Effects of conjugated equine estrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices. S AfrMedJ. 1990;77:281-285.
26. Kritz-Silverstein D, Barrett-Connor E, Morion DJ, Wingard DL. Hysterectomy status and preventive health behaviors in older women. J Women's Health. 1993;2:223-229.
27. Brett KM, Madans JH. Hysterectomy use: the correspondence between self-reports and hospital records. Am J Public Health. 1994:84:1653-1655.
28. Chilvers CE, Pike MC, Taylor CN, Hermon C, Crossley B, Smith SJ. General practitioner notes as a source of information for case-control studies in young women. J Epidemiol Community Health. 1994;48:92-97.
29. Irwin KL, Wingo PA, Lee NC. Agreement on self-reported ovarian number following gynecologic surgery with medical record reports. J Clin Epidemiol. 1990;43:181-187.
30. Pokras R, Hufnagel V. Hysterectomies in the United States, 1965-84. National Center for Health Statistics. Vital Health Stat. [13], 1987, 92. DHHS publication PHS - 88-1753.
31. Meade TW, Berra A. Hormone replacement therapy and cardiovascular disease. BrMedBull. 1992;48:276-308.
32. Grady D, Rubin SM, Pettiti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann hit Med. 1992;117:1016-1037.